Salient Capital Advisors’s Westlake Chemical Partners WLKP Stock Holding History

Salient Capital Advisors’s Portfolio WLKP Stock Details WLKP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-58,967	Closed	-$1.56M	–	70
2019 Q4	$1.56M	Sell	58,967 -22,934	-28%	-$527K	0.04%	43
2019 Q3	$1.9M	Sell	81,901 -81,902	-50%	-$1.86M	0.05%	40
2019 Q2	$4.03M	Sell	163,803 -366,300	-69%	-$8.45M	0.1%	36
2019 Q1	$11.9M	Buy	530,103 +504,064	+1,936%	+$11.5M	0.28%	29
2018 Q4	$628K	Hold	26,039	–	–	0.02%	53
2018 Q3	$648K	Hold	26,039	–	–	0.01%	53
2018 Q2	$638K	Sell	26,039 -9,287	-26%	-$216K	0.01%	62
2018 Q1	$790K	Sell	35,326 -4,695	-12%	-$111K	0.02%	59
2017 Q4	$999K	Buy	40,021 +3,304	+9%	+$74.7K	0.02%	49
2017 Q3	$833K	Buy	+36,717	New	+$885K	0.02%	53

Other funds holding WLKP

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EIP

Energy Income Partners Westport, Connecticut $6.22B AUM 18.97% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DPIM

Duff & Phelps Investment Management Chicago, Illinois $9.63B AUM 11.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Salient Capital Advisors's WLKP Position: Q1 2020 in Review

Salient Capital Advisors sold out of Westlake Chemical Partners (WLKP) in Q1 2020, closing a stake of 58,967 shares — an estimated $1.56M sold.

Salient Capital Advisors first reported a position in WLKP in Q3 2017 and held it in 10 quarters. The position peaked at $11.9M in Q1 2019. 46 funds tracked by Wall St. Rank hold WLKP as of Q1 2020.

Salient Capital Advisors reported no remaining Westlake Chemical Partners position as of Q1 2020 after selling out during the quarter.
Salient Capital Advisors sold 58,967 Westlake Chemical Partners shares in Q1 2020, an estimated $1.56M.
Salient Capital Advisors first reported a position in Westlake Chemical Partners in Q3 2017 and held it in 10 quarters.
Salient Capital Advisors's Westlake Chemical Partners position peaked at $11.9M in Q1 2019.
46 funds tracked by Wall St. Rank held Westlake Chemical Partners as of Q1 2020.

Based on Salient Capital Advisors's 13F filing for Q1 2020, filed 12 May 2020.